Mylotarg

Active Ingredient(s): Gemtuzumab Ozogamicin
FDA Approved: * May 17, 2000
Pharm Company: * WYETH PHARMS INC
Category: Cancer

Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate (a drug-linked monoclonal antibody) that is used to treat acute myeloid leukemia.[4][5] The most common grade 3 and higher adverse reactions that occurred during Induction 1 and Intensification 2 in ≥ 5% of people who received gemtuzumab ozogamicin were infection, febrile neutropenia, decreased appetite, hyperglycemia, mucositis, hypoxia, hemorrhage, increased transam... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Mylotarg 5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0008-4510
Labeler:
Wyeth Pharmaceuticals Inc., a Subsidiary of Pfizer Inc.

Popular Topics

Mylotarg

My mom died two weeks after receiving two doses of mylotarg in May of 2010. Since her death certificate says her death w...

2 REPLIES